Image credit: Encare
Stockholm-based Encare, a SaaS solution that helps healthcare providers implement best practices for surgical care to improve patient outcomes, announced on Monday that it has secured €1.5M in a fresh round of funding.
The Swedish health tech company says that the funds will help support the company’s continued expansion and product development, and to enter new international markets.
Existing shareholders, and some new investors through the Society network, took part in the financing round.
Digitalising science to help save lives
Founded in 2009 by Prof. Olle Ljungqvist, Encare is a health technology firm that develops a SaaS solution to improve surgical outcomes.
Its cloud-based interactive system enables healthcare practitioners to adhere to worldwide treatment recommendations prior to, during, and after major surgical procedures.
Encare claims that its approach has the potential to prevent needless deaths and complications, saving the global healthcare business enormous money.
The company’s service includes programmes, so-called protocols, that are based on the international recommendations ERAS (Enhanced Recovery After Surgery), which are the product of research and best practices worldwide.
Olle Ljungqvist is one of the founders of the ERAS Society.
The ERAS Society, a scientific non-profit organisation, creates perioperative care protocols and enhances postoperative recovery via research, instruction, auditing, and the use of best practices that are supported by scientific study and evidence.
A variety of peer-reviewed publications that create, modify, and update best practices have been released by the ERAS Society.
By following these ERAS standards, doctors can prevent problems, speed up patient recovery, and shorten hospital stays.
Capital utilisation
Encare reports that it has a significant market presence, servicing over 150 hospitals globally, and has grown by more than 30 per cent in the previous year.
With the raised funds, it will increase revenue by extending sales to existing customers and attracting new ones.
Rasmus Waller, CEO of Encare, says, “Thanks to the continued support from our investors, we can continue our expansion and work towards our mission to positively impact the lives of millions of patients undergoing surgery worldwide.”
“By supporting healthcare providers in implementing best practices in surgical care, Encare can contribute to reducing the number of preventable deaths and complications during surgery.”
Additionally, the company will give priority to product development to meet particular market demands. This strategic move will help the company’s expansion into new key international markets, including the US.
[ad_2]